Wednesday, December 21, 2016

Actelion says enters into exclusive discussions with J&J

ZURICH, Dec 21 (Reuters) - Actelion said on

Wednesday it has entered exclusive negotiations with U.S.

healthcare company Johnson & Johnson regarding what the

Swiss biotech company called a "possible strategic transaction".

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)